Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 11/30/2024 | 08/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 42.18% | 44.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 42.18% | 44.10% | |||
| Cost of Revenue | 57.05% | 48.96% | |||
| Gross Profit | 24.89% | 38.83% | |||
| SG&A Expenses | 12.89% | 26.19% | |||
| Depreciation & Amortization | -1.54% | 8.94% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 48.91% | 39.24% | |||
| Operating Income | 21.07% | 61.85% | |||
| Income Before Tax | 18.89% | 89.16% | |||
| Income Tax Expenses | 42.31% | -5.20% | |||
| Earnings from Continuing Operations | 8.99% | 226.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.99% | 226.49% | |||
| EBIT | 21.07% | 61.85% | |||
| EBITDA | 20.02% | 57.69% | |||
| EPS Basic | 50.00% | 140.96% | |||
| Normalized Basic EPS | 62.50% | 37.31% | |||
| EPS Diluted | 50.00% | 140.96% | |||
| Normalized Diluted EPS | 62.50% | 37.31% | |||
| Average Basic Shares Outstanding | -27.35% | 34.83% | |||
| Average Diluted Shares Outstanding | -27.35% | 34.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||